Seed-stage partner for biotech, healthtech, and solutions that improve patient outcomes and health-system performance
Stage
Pre-seed and seed
Approach
We size investments to company needs and maintain reserves for follow-on
Sectors
Therapeutics; platforms and tools; diagnostics; devices; health IT/digital; science-anchored consumer
Geography
Primarily US, with international founders and strong ties across North American research hubs
David Naylor
MD, PhD, Rhodes Scholar. President emeritus and former dean of medicine at the University of Toronto. Co-chaired Canada's COVID-19 Immunity Task Force.
Ilse Treurnicht
PhD, Rhodes Scholar. Led the development of MaRS, North America's largest innovation hub, from idea to scale. Operator, impact investor, and advisor.
Paul Kudlow
MD, PhD. Co-founded TrendMD, the world's largest native ad network in the pharma space. Teaches psychiatry at the University of Toronto and practices medicine.
Andrew Lee
MD, PhD. Co-founded Clipboard Health (unicorn). Co-created Stanford's StartX Med, which has seeded 500+ biotech startups, leading to 100+ FDA approvals and 20 IPOs/unicorns.
Past performance is not indicative of future results. This website is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security or investment product. Any such offer or solicitation will be made only via confidential offering documents and in compliance with applicable laws.